Fan Zhu

Dr. Fan Zhu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2020 in Pancreas
Verified
Journal Article
Closed access
FZFan Zhu
Fan Zhu
HWHaoyu Wang
Haoyu Wang
HAHani Md Ashamalla
Hani Md Ashamalla
Objectives: The aim of this study was to investigate racial and socioeconomic disparities for patients with pancreatic cancer across different facility types. Methods: The National Cancer Database was queried for pancreatic cancer cases from 2004 to 2015. Along with propensity score matching analysis, multivariate logistic and Cox model were used to assess effects of facility type, race, elements of socioeconomics on receipt of treatment, time to treatment, and overall survival, separately. Results: Among 223,465 patients, 44.6%, 42.1%, and 13.3% were treated at academic, community, and integrated facilities, respectively. Private insurance was associated with more treatment (odds ratio, 1.41; P < 0.001) and better survival [hazards ratio (HR), 0.84; P < 0.001]. Higher education was associated with earlier treatment (HR, 1.09; P < 0.001). African Americans had less treatment (odds ratio, 0.97; P = 0.04) and delayed treatment (HR, 0.89; P < 0.001) despite later stage at diagnosis. After adjusting for socioeconomic status, African Americans had similar survival (HR, 0.99; P = 0.11) overall and improved survival (HR, 0.95; P = 0.016) at integrated facilities. Conclusions: Higher socioeconomic status was associated with better treatment and survival. After adjusting for socioeconomic disparities, race did not affect survival. Less racial disparity was observed at integrated facilities.

22 January 2025 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
JGJuan A. García-Alvarez
Juan A. García-Alvarez
EPEric Paulson
Eric Paulson
KKKristofer Kainz
Kristofer Kainz
LPLindsay Puckett
Lindsay Puckett
MSMonica E. Shukla
Monica E. Shukla
ATAn Tai
An Tai


4 March 2020 in Pancreas
Verified
Journal Article
Closed access
FZFan Zhu
Fan Zhu
HWHaoyu Wang
Haoyu Wang
AGAdel Mbbch Guirguis
Adel Mbbch Guirguis
HAHani Md Ashamalla
Hani Md Ashamalla
Objectives The aim of this study was to determine the survival benefits by adjuvant radiation therapy (RT) in pancreatic cancer patients with different total lymph nodes examined (TNE), number of positive lymph nodes (NPN), and lymph nodes ratio (LNR). Methods National Cancer Database was queried for nonmetastatic pancreatic cancer patients from 2004 to 2015. Cox models were utilized. Interaction terms were applied to evaluate the effect of RT in different NPN, LNR, and margin strata. Multivariate analysis was performed. Results Of 19,759 patients identified, 10,910 patients qualified. Compared with TNE of 1 to 9, TNE of 10 to 14, 15 to 19, 20 to 24, and 25 or greater had progressive overall survival (OS) benefits. Adjuvant RT had similar OS benefits among them. In negative margin patients, adjuvant RT improved OS when NPN was 2 to 3 (hazards ratio [HR], 0.84; P = 0.01) or LNR was 0.15 to 0.25 (HR, 0.79; P = 0.002). In positive margin patients, adjuvant RT nonsignificantly improved OS when NPN was 1 to 3 (HR, 0.89; P = 0.36) or when NPN was 4 or greater (HR, 0.79; P = 0.07). Conclusions Higher TNE correlates with better survival. Adjuvant RT may not compensate for inadequate lymph node dissection. Adjuvant RT improves survival in negative-margin patients with 2 to 3 positive lymph nodes or LNR of 0.15 to 0.25.

24 December 2022 in Journal of Genetics
Verified
Journal Article
Closed access
PDF file
LJLin Jia
Lin Jia
WWWenzhe Wang
Wenzhe Wang
LHliu hui
liu hui
FZFan Zhu
Fan Zhu
YHYunfang Huang
Yunfang Huang

6 January 2022 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
FZFan Zhu
Fan Zhu
JSJ. Shogan
J. Shogan
HWH. Wang
H. Wang
HAH. Ashamalla
H. Ashamalla